These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4265280)

  • 21. Delaying the onset of Huntington's in mice.
    van Dellen A; Blakemore C; Deacon R; York D; Hannan AJ
    Nature; 2000 Apr; 404(6779):721-2. PubMed ID: 10783874
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuropathologic correlation of computerized tomography in Huntington's disease.
    Terrence CF; Rao G
    South Med J; 1980 Jun; 73(6):817-8. PubMed ID: 6446759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease.
    Aylward EH
    Brain Res Bull; 2007 Apr; 72(2-3):152-8. PubMed ID: 17352939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phenocopy of Huntington's disease: lacunar infarcts of the corpus striatum.
    Folstein S; Abbott M; Moser R; Parhad I; Clark A; Folstein M
    Johns Hopkins Med J; 1981 Mar; 148(3):104-8. PubMed ID: 6451753
    [No Abstract]   [Full Text] [Related]  

  • 25. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caudate nucleus atrophy in Huntington's disease and its relationship with clinical and genetic parameters.
    Roth J; Klempìi J; Jech R; Zidovská J; Uhrová T; Doubek P; Ulmanová O; Brozová H; Volfová M; Serranová T; Ruzicka E
    Funct Neurol; 2005; 20(3):127-30. PubMed ID: 16324236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Juvenile Huntington's disease.
    Srivastava T; Lal V; Prabhakar S
    Neurol India; 1999 Dec; 47(4):340-1. PubMed ID: 10625918
    [No Abstract]   [Full Text] [Related]  

  • 28. Striatal neural grafting improves cortical metabolism in Huntington's disease patients.
    Gaura V; Bachoud-Lévi AC; Ribeiro MJ; Nguyen JP; Frouin V; Baudic S; Brugières P; Mangin JF; Boissé MF; Palfi S; Cesaro P; Samson Y; Hantraye P; Peschanski M; Remy P
    Brain; 2004 Jan; 127(Pt 1):65-72. PubMed ID: 14607797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An autopsy case of late-onset chorea].
    Okuyama H; Mizutani T; Bando M; Mitani K; Nagura H; Yamanouchi H; Murata M; Goto J
    No To Shinkei; 1996 Aug; 48(8):741-6. PubMed ID: 8797208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation.
    Capetian P; Knoth R; Maciaczyk J; Pantazis G; Ditter M; Bokla L; Landwehrmeyer GB; Volk B; Nikkhah G
    Neuroscience; 2009 May; 160(3):661-75. PubMed ID: 19254752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging in Huntington disease.
    Simmons JT; Pastakia B; Chase TN; Shults CW
    AJNR Am J Neuroradiol; 1986; 7(1):25-8. PubMed ID: 2937278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rigidity and Huntington's chorea. The infantile form of Huntington's disease. (Study of an anatomo-clinical case)].
    Brion S; Comoy C
    Rev Neurol (Paris); 1965 Mar; 112(3):183-99. PubMed ID: 4221602
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible cellular mechanism accounting for the cell type-specific vulnerability in Huntington's disease.
    Centonze D; Giacomini P; Tolu M; Bernardi G; Calabresi P
    Funct Neurol; 2000; 15(4):253-8. PubMed ID: 11213528
    [No Abstract]   [Full Text] [Related]  

  • 34. Striatal gray matter loss in Huntington's disease is leftward biased.
    Mühlau M; Gaser C; Wohlschläger AM; Weindl A; Städtler M; Valet M; Zimmer C; Kassubek J; Peinemann A
    Mov Disord; 2007 Jun; 22(8):1169-73. PubMed ID: 17394246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parasynaptic corpora amylacea in the striatum.
    Averback P
    Arch Pathol Lab Med; 1981 Jun; 105(6):334-5. PubMed ID: 6453566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease.
    Klöppel S; Draganski B; Golding CV; Chu C; Nagy Z; Cook PA; Hicks SL; Kennard C; Alexander DC; Parker GJ; Tabrizi SJ; Frackowiak RS
    Brain; 2008 Jan; 131(Pt 1):196-204. PubMed ID: 18056161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.
    Richfield EK; Herkenham M
    Ann Neurol; 1994 Oct; 36(4):577-84. PubMed ID: 7944290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis of Huntington's chorea; its problems and its value].
    Husquinet H
    Acta Psychiatr Belg; 1971 Jan; 71(1):56-63. PubMed ID: 4254820
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of the striatum in rule application: the model of Huntington's disease at early stage.
    Teichmann M; Dupoux E; Kouider S; Brugières P; Boissé MF; Baudic S; Cesaro P; Peschanski M; Bachoud-Lévi AC
    Brain; 2005 May; 128(Pt 5):1155-67. PubMed ID: 15788544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus.
    Ma L; Nicholson LF
    Brain Res; 2004 Aug; 1018(1):10-7. PubMed ID: 15262199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.